Bibliografia scientifica essenziale sulla Sensibilità Chimica Multipla

 

1. ACOEM Position Statement. Multiple chemical sensitivities: idiopathic environmental intolerance. American College of Occupational and Environmental Medicine. J Occup Environ Med, 1999;41:940-942. 

2. Anonimo. [No authors listed] Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health. 1999 May-Jun;54(3):147-9. 

3. Ashford NA and Miller CS: Chemical Exposures: Low Levels and High Stakes, 2nd edition.Wiley & Sons, New York, 1998. 

4. Baines CJ, McKeown-Eyssen GE, Riley N, Cole DE, Marshall L, Loescher B,Baines CJ, McKeown-Eyssen GE, Riley N, Cole DE, Marshall L, Loescher B, Jazmaji V: Case-control study of multiple chemical sensitivity, comparing haematology, biochemistry, vitamins and serum volatile organic compound measures. Occup Med (Lond). 2004;54:408-18. 

5. Bartha L, Baumzweiger W et al.: Multiple Chemical Sensitivity. A 1999 Consensus; 1999, Arch Environ Health, 54: 147-149 

6. Bell IR, Amend D, Peterson JM, Schwartz GE, Miller CS: Neuropsychiatric and somatic characteristics of young adults with and without self-reported chemical odor intolerance and chemical sensitivity. Arch Environ Health, 1996;51:9-20. 

7. Bell IR, Schwartz GE, Baldwin CM, Hardin EE, Klimas NG, Kline JP et al: Individual intolerance in neural sensitization and the role of context in illness from low-level environmental chemical exposure. Environ Health Perspect, 1997;105 suppl 2:539-547. 

8. Caress SM, Steinemann AC: Prevalence of Multiple Chemical Sensitivities: a population-based study in the Southeastern United States. Am J Public Health, 2004;94:746-747. 

9. Cullen MR, Pace PE, Redlich CA: The experience of the Yale occupational and environmental medicine clinics with multiple chemical sensitivities, 1986-1991. Toxicol Ind Health, 1992;8:15-19. 

10. Cullen MR: The worker with multiple chemical sensitivities: an overview. Occup Med, 1987;2:655-661. 

11. Dalton P, Hummel T: Chemosensory function and response in idiopathic environmental intolerance.Occup Med, 2000;15:539-556. 

12. Dearman RJ, Kimber I. Cytokine profiling and chemical allergy. Toxicol Appl Pharmacol. 2002 Dec 15;185 (3):228-9 

13. Fiedler N, Giardino N, Natelson B, Ottenweller JE, Weisel C, Lioy P, Lehrer Fiedler N, Kipen HM. Controlled exposures to volatile organic compounds in sensitive groups. Ann N Y Acad Sci. 2001 Mar;933:24-37. Review. 

14. Greene GJ, Kipen HM. The vomeronasal organ and chemical sensitivity: a hypothesis. Environ Health Perspect. 2002 Aug;110 Suppl 4:655-61. Review. 

15. IPCS, Conclusions and recommendations of a workshop on multiple chemical sensitivity. Regul Toxicol Pharmacol, 1996;24:188-189.6 

16. Editorial: Multiple chemical sensitivity: A 1999 Consensus, Arch. Env. Health 54: 147-149, 1999 (lo abbiamo originale sul sito). 

17. Kosta, L: Consensus definition of MCS proposed, The Human Ecologist 84: 10, 1999. 

18. Ashford, N.A. and Miller, C.S.: Chemical Exposures; Low Levels and High Stakes. Van Nostrand Reinhold, New York, 1991 and 1998 (lo abbiamo originale in archivio, in vedita da Macro Edizioni www.macrolibrarsi.it). 

19. Meggs, W.J.; Neurogenic inflammation and sensitivity to environmental chemicals. Environ. Health Perspect 101: 234-238, 1993 (lo abbiamo originale in archivio). 

20. Ishikawa, S.: Chemical Sensitivity. Jiritsu Shinkel 29; 3-8, 1994. (in Japanese) 

21. Ishikawa, S.: Ophthalmopathy due to environmental contaminants. Nippon Ganka Gakkai Wasshi 100: 417-432, 1996. (in Japanese) 

22. Shirakawa, S. Ishikawa, S., Rea, W.J. and Johson, A.R.: Evaluation of the autonomic nervous system response by pupillographical study in the chemical sensitive patient. Environmental Medicine 121-127, 1991. 

23. Miyata, M. and Namba, T.: Clinical features of multiple chemical sensitivity. Jiritsu Shinkei 33: 257-260, 1996. (in Japanese) 

24. Ishikawa, S.: Indefinite complaints and trace chemical substances: diagnostic criteria for chemical sensitivity. Shinshin Igaku 38: 95-102, 1998. (in Japanese) 

25. Ishikawa, S. and Miyata, M.: Special Issue of the Multiple Chemical Sensitivity (MCS). Allergy and Immunology 6: 34-42, 1999. (in Japanese) 

26. Chemical sensitivity: Diagnostic Criteria Pamphlet. The Report of the Allergy Research Group of the Prolonged Chronic Disease Comprehensive Research Project, Ministry of Health and Welfare, 1997. 

27. Diagnostic criteria for chemical sensitivity. Nippon Iji Shinpo, 1998, 25-29. (in Japanese) 

28. The “Textbook of Clinical Occupational and Environmental Medicine (Saunders WB, Philadelphia)” written by Rosenstock and Cullen describes “MCS; multiple chemical sensitivity”. 

29. Miller, C.S. and Prihoda, T.J.: The environmental exposure and sensitivity inventory (EESI): A standardized approach for measuring chemical intolerances for research and clinical applications. Toxicology and Indust Health 15: 370-385, 1999 (lo abbiamo originale in archivio). 

30. Bell, I.R., Schwartz, G.E., Baldwin, C.M. and Hardin, E.E.: Neural sensitization and physiological markers in multiple chemical sensitivity. Regul Toxicol Pharmacol 24: 39-47, 1996 (lo abbiamo originale sul sito). 

31. Overstreet, D.H., Miller, C.S. Janowsky, D.S. and Russel, R.W.: Potential animal model of multiple chemical sensitivity with cholinergic sensitivity. Toxicology 29: 119-134, 1996 (lo abbiamo originale in archivio). 

32. Shih, D.M., Gu L. Xia Y. et. al. : Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394-287, 1998. 

33. Hoeck AD, Pall ML: will vitamin D supplementation ameliorate diseases characterized by chronic inflammation and fatigue? Medical hypotheses 76(2011). 

34. Maes M et al. Not in the mind of neurastenic lazybones but in the cell nucleus : patients with chronic fatigue syndrome have increased production of NF K beta. Neuro Endocrinal Lett 2007. 

35. Chatterjee M. Vitamin D and genomic stability. Mutat. Res 2001 

36. D’Ambrosio D et al . Inhibition of IL-12 production by 1,25 dihydroxyvitamin D3. Involvement of NF K B dpown regulation in transcriptional repression of the p40 gene. J clin Invest 1998. 

37. Caress S.M et al. A review of a two-phase population study of MCS. A.C. 2003 

38. Arcari Morni, D'Eugenio A, Aufiero F, Bioterapia nutrizionale - Nutrizione e funzioni organiche., 2004, pp. 47-57. ISBN 88-7447-198-X 

39. (EN) J L Gollan, C Bateman, B H Billing (1976). Effect of dietary composition on the unconjugated hyperbilirubinaemia of Gilbert's syndrome. Gut 17 (5): 335–340. DOI:10.1136/gut.17.5.335. PMID 1278716. 

40. Marcuello E, Altés A, Menoyo A, Del Rio E, Gómez-Pardo M, Baiget M (2004). UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer.. Br J Cancer 91 (4): 678-82. PMID 15280 

41. C. de Luca,G. Scordo, E.Cesareo,D. Raskovic,G.Genovesi, and L. Korkina, “Idiopathic environmental intolerances (IEI): from molecular epidemiology to molecular medicine,” Indian Journalof Experimental Biology, vol. 48, no. 7, pp. 625–635, 2010. 

42. L. Korkina, M. G. Scordo, I. Deeva, E. Cesareo, and C. de Luca, “The chemical defensive system in the pathobiology of idiopathic environment-associated diseases,” Current Drug Metabolism, vol. 10, no. 8, pp. 914–931, 2009. 

43. H. M. Kipen and N. Fiedler, “Environmental factors in medically unexplained symptoms and related syndromes: the evidence and the challenge,” Environmental Health Perspectives, vol. 110, supplement 4, pp. 597–599, 2002. 

44. L. H. Hetherington and J. M. Battershill, “Review of evidence for a toxicological mechanism of idiopathic environmental intolerance,” Human & Experimental Toxicology, vol. 32, no. 1, pp. 3–17, 2013. 

45. S. J. Genuis, “Chemical sensitivity: pathophysiology or pathopsychology?” Clinical Therapeutics, vol. 35, no. 5, pp. 572–577, 2013. 

46. G. McKeown-Eyssen, C. Baines, D. E. C. Cole et al., “Casecontrol study of genotypes in multiple chemical sensitivity: CYP2D6, NAT1, NAT2, PON1, PON2 and MTHFR,” International Journal of Epidemiology, vol. 33, no. 5, pp. 971–978, 2004. 

47. D. Caccamo, E. Cesareo, S. Mariani et al., “Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population,” Oxidative Medicine and Cellular Longevity, vol. 2013,Article ID 831969, 9 pages, 2013. 

48. X. Cui, X. Lu, M. Hiura, M. Oda, W. Miyazaki, and T. Katoh, “Evaluation of genetic polymorphisms in patients with multiple chemical sensitivity,” PLoS ONE, vol. 8, no. 8,Article IDe73708, 2013. 

49. C. de Luca, J. C. S. Thai, D. Raskovic et al., “Metabolic and genetic screening of electromagnetic hypersensitive subjects as a feasible tool for diagnostics and intervention,” Mediators of Inflammation, vol. 2014, Article ID 924184, 14 pages, 2014. 

50. C. De Luca, M. G. Scordo, E. Cesareo et al., “Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobioticmetabolizing enzymes,” Toxicology and Applied Pharmacology, vol. 248, no. 3, pp. 285–292, 2010. 

51. C. de Luca,D. Raskovic, V. Pacifico, J. C. S.Thai, and L. Korkina, “The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances,” International Journal of Environmental Research and Public Health, vol. 8, no. 7, pp. 2770–2797, 2011.

52. M. L. Pall, “NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organic solvents as the mechanism of chemical sensitivity inmultiple chemical sensitivity,”TheFASEB Journal, vol. 16, no. 11, pp. 1407–1417, 2002. 

53. Y. Vodovotz, P. K. M. Kim, E. Z. Bagci et al., “nflammatory modulation of hepatocyte apoptosis by nitric oxide: in vivo,invitro, and in silico studies,” Current Molecular Medicine, vol. 4, no. 7, pp. 753–762, 2004. 

54. M. L. Pall and J. D. Satterlee, “Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome, and posttraumatic stress disorder,” Annals of the New York Academy of Sciences, vol. 933, pp. 323–329, 2001. 

55. M. L. Pall, “Elevated nitric oxide/peroxynitrite theory of multiple chemical sensitivity: central role of N-methyl-D-aspartate receptors in the sensitivity mechanism,” Environmental Health Perspectives, vol. 111, no. 12, pp. 1461–1464, 2003. 

56. L. I. Holla, A. Stejskalova, V. Znojil, and A. Vasku, “Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases,” Clinical & ExperimentalAllergy, vol. 36, no. 12, pp. 1592–1601, 2006. 

57. S. Konno, N. Hizawa, E. Yamaguchi, E. Jinushi, and M. Nishimura, “(CCTTT)𝑛 repeat polymorphism in the NOS2 gene promoter is associated with atopy,” Journal of Allergy and Clinical Immunology, vol. 108, no. 5, pp. 810–814, 2001. 

58. J. Batra, T. P. Singh, U. Mabalirajan, A. Sinha, R. Prasad, and B. Ghosh, “Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels,” Thorax, vol. 62, no. 1, pp. 16–22, 2007. 

59. F. M. Gonc¸alves, M. R. Luizon, J. G. Speciali, A. Martins-Oliveira, F. Dach, and J. E. Tanus-Santos, “Interaction among nitric oxide (NO)-related genes in migraine susceptibility,” Molecular and Cellular Biochemistry, vol. 370, no. 1-2, pp. 183– 189, 2012. 

60. S. S. Dhillon, L. A. Mastropaolo, R. Murchie et al., “Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease,” Clinical and Translational Gastroenterology, vol. 5, no. 1, article e46, 2014. 

61. Y.Miyamoto, Y. Saito, M. Nakayama et al., “Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a −786T→C mutation associated with coronary spastic angina,” Human Molecular Genetics, vol. 9, no. 18, pp. 2629–2637, 2000. 

62. C. S. Miller and T. J. Prihoda, “The environmental exposure and sensitivity inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications,” Toxicology and Industrial Health, vol. 15, no. 3-4, pp. 370–385, 1999 

63. E. Schnakenberg, K.-R. Fabig, M. Stanulla et al., “A crosssectional study of self-reported chemical-related sensitivity is associated with gene variants of drug-metabolizing enzymes,” Environmental Health, vol. 6, article 6, 2007. 

64. G. A. Wiesm¨uller, H. Niggemann, W. Weißbach et al., “Sequence variations in subjects with self-reported multiple chemical sensitivity (sMCS): a case-control study,” Journal of Toxicology and EnvironmentalHealth Part A: Current Issues, vol. 71, no. 11-12, pp. 786–794, 2008. 

65. N. D. Berg, H. Berg Rasmussen, A. Linneberg et al., “Genetic susceptibility factors formultiple chemical sensitivity revisited,” International Journal of Hygiene and Environmental Health, vol. 213, no. 2, pp. 131–139, 2010. 

66. E. Bouzigon, F. Monier, M. Boussaha et al., “Associations between nitric oxide synthase genes and exhaled NO-related phenotypes according to asthma status,” PLoS ONE, vol. 7, no. 5, Article ID e36672, 2012. 

67. C. H. Sponton, R. Esposti, C. M. Rodovalho et al., “Thepresence of theNOS3 gene polymorphism for intron 4 mitigates the beneficial effects of exercise training on ambulatory blood pressure monitoring in adults,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 306, no. 12, pp. H1679–H1691, 2014. 

68. T. D. O. S. Mansur, F. M. Gonc¸alves, A. Martins-Oliveira et al., “Inducible nitric oxide synthase haplotype associated with migraine and aura,” Molecular and Cellular Biochemistry, vol.364, no. 1-2, pp. 303–308, 2012. 

69. R. Er¨oz, A. Bahadir, S. Dikici, and S. Tasdemir, “Association of endothelial nitric oxide synthase gene polymorphisms (894G/T, -786T/C, G10T) and clinical findings in patients with migraine,” NeuroMolecular Medicine, vol. 16, no. 3, pp. 587–593, 2014. 

70. M. Pascual, C. Sanz, M. Isidoro-Garc´ıa et al., “(CCTTT)n polymorphismofNOS2Ain nasal polyposis and asthma: a casecontrol study,” Journal of Investigational Allergology and Clinical Immunology, vol. 18, no. 4, pp. 239–244, 2008

71. Role of polymorphisms of inducible nitric oxide synthase and endothelial nitric oxide synthase in idiopathic environmental intolerances. De Luca C, Gugliandolo A, Calabrò C, Currò M, Ientile R, Raskovic D, Korkina L, Caccamo D. Mediators Inflamm. 2015;2015:245308. doi: 10.1155/2015/245308. Epub 2015 Mar 24. PMID: 25878398 

72. Evaluation of genetic polymorphisms in patients with multiple chemical sensitivity. Cui X, Lu X, Hiura M, Oda M, Miyazaki W, Katoh T. PLoS One. 2013 Aug 13;8(8):e73708. doi: 10.1371/journal.pone.0073708. eCollection 2013. PMID: 23967348 

73. Xenobiotic sensor- and metabolism-related gene variants in environmental sensitivity-related illnesses: a survey on the Italian population. Caccamo D, Cesareo E, Mariani S, Raskovic D, Ientile R, Currò M, Korkina L, De Luca C. Oxid Med Cell Longev. 2013;2013:831969. doi: 10.1155/2013/831969. Epub 2013 Jul 7. PMID: 23936614 

74. The search for reliable biomarkers of disease in multiple chemical sensitivity and other environmental intolerances. De Luca C, Raskovic D, Pacifico V, Thai JC, Korkina L. Int J Environ Res Public Health. 2011 Jul;8(7):2770-97. doi: 10.3390/ijerph8072770. Epub 2011 Jul 1. Review. PMID: 21845158 Free PMC Article Similar articles Select item 20430047 7. 

75. Biological definition of multiple chemical sensitivity from redox state and cytokine profiling and not from polymorphisms of xenobiotic-metabolizing enzymes. De Luca C, Scordo MG, Cesareo E, Pastore S, Mariani S, Maiani G, Stancato A, Loreti B, Valacchi G, Lubrano C, Raskovic D, De Padova L, Genovesi G, Korkina LG. Toxicol Appl Pharmacol. 2010 Nov 1;248(3):285-92. doi: 10.1016/j.taap.2010.04.017. Epub 2010 Apr 27. PMID: 20430047 Similar articles